首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2565篇
  免费   78篇
  国内免费   80篇
耳鼻咽喉   2篇
儿科学   94篇
妇产科学   16篇
基础医学   166篇
口腔科学   41篇
临床医学   295篇
内科学   937篇
皮肤病学   4篇
神经病学   74篇
特种医学   44篇
外科学   83篇
综合类   211篇
预防医学   142篇
眼科学   9篇
药学   458篇
  2篇
中国医学   112篇
肿瘤学   33篇
  2023年   78篇
  2022年   107篇
  2021年   117篇
  2020年   116篇
  2019年   121篇
  2018年   102篇
  2017年   69篇
  2016年   74篇
  2015年   67篇
  2014年   236篇
  2013年   178篇
  2012年   158篇
  2011年   175篇
  2010年   131篇
  2009年   128篇
  2008年   111篇
  2007年   117篇
  2006年   76篇
  2005年   83篇
  2004年   48篇
  2003年   28篇
  2002年   40篇
  2001年   28篇
  2000年   27篇
  1999年   33篇
  1998年   21篇
  1997年   20篇
  1996年   11篇
  1995年   19篇
  1994年   27篇
  1993年   8篇
  1992年   18篇
  1991年   15篇
  1990年   8篇
  1989年   4篇
  1988年   10篇
  1987年   6篇
  1986年   11篇
  1985年   10篇
  1984年   11篇
  1983年   9篇
  1982年   10篇
  1981年   12篇
  1980年   8篇
  1979年   7篇
  1978年   5篇
  1977年   8篇
  1976年   7篇
  1975年   4篇
  1973年   4篇
排序方式: 共有2723条查询结果,搜索用时 46 毫秒
41.
  1. Download : Download high-res image (238KB)
  2. Download : Download full-size image
  相似文献   
42.
43.
44.
目的:探究丙氨酸氨基转移酶(ALT)快速检测在血站血液采集前应用的意义。方法以2014年5月—2014年8月血站采集的血液样本为研究对象,作为实验组。实验组在采集血液样本前进行ALT快速检测,统计血液报废情况;以2013年5月—2013年8月血站采集前未行ALT快速检测的血液样本为对照组,统计报废情况。对照组与实验组结果进行对比。对已知ALT阳性和ALT阴性的样本各10例,这20例样本均进行ALT快速检测和实验室检测,比较两种检验的结果。结果血站采集血液前进行ALT快速检测血液报废率为1.54%,结果低于未进行ALT快速检测的血液报废率7.08%,差异有统计学意义(<0.05)。ALT快速检测与实验室检测结果差异无统计学意义(P>0.05)。结论 ALT快速检测结果准确性高,在血站血液采集前应用ALT快速检测可以降低血液报废率,值得临床推广应用。  相似文献   
45.

Aim:

To develop a population pharmacokinetic (PopPK) model of tacrolimus in healthy Chinese volunteers and liver transplant recipients for investigating the difference between the populations, and for potential individualized medication.

Methods:

A set of 1100 sparse trough concentration data points from 112 orthotopic liver transplant recipients, as well as 851 dense data points from 40 healthy volunteers receiving a single dose of tacrolimus (2 mg, po) were collected. PopPK model of tacrolimus was constructed using the program NONMEM. Related covariates such as age, hepatic and renal functions that were potentially associated with tacrolimus disposition were evaluated. The final model was validated using bootstrapping and a visual predictive check.

Results:

A two-compartment model of tacrolimus could best describe the data from the two populations. The final model including two covariates, population (liver transplant recipients or volunteers) and serum ALT (alanine aminotransferase) level, was verified and adequately described the pharmacokinetic characteristics of tacrolimus. The estimates of V2/F, Q/F and V3/F were 22.7 L, 76.3 L/h and 916 L, respectively. The estimated CL/F in the volunteers and liver transplant recipients was 32.8 and 18.4 L/h, respectively. Serum ALT level was inversely related to CL/F, whereas age did not influence CL/F. Thus, the elderly (≥65 years) and adult (<65 years) groups in the liver transplant recipients showed no significant difference in the clearance of tacrolimus.

Conclusion:

Compared with using the sparse data only, the integrating modeling technique combining sparse data from the patients and dense data from the healthy volunteers improved the PopPK analysis of tacrolimus.  相似文献   
46.
  1. Download : Download high-res image (425KB)
  2. Download : Download full-size image
  相似文献   
47.
48.
《Vaccine》2015,33(28):3200-3207
PurposeIn April 2007, Panama introduced Hepatitis A universal vaccination using a two-dose schedule (Havrix® junior; GSK Vaccines, Belgium). We assessed the impact of this hepatitis A vaccine three years after it was recommended for universal mass vaccination in Panama.Materials and methodsHepatitis A vaccination impact was assessed using two different approaches. The first approach used retrospective data (incidence and number of cases for all age groups), collected from the passive surveillance of the Epidemiologic Surveillance System of the Ministry of Health of hepatitis A and unspecified hepatitis before (2000–2006) and after (2008–2010) introduction of hepatitis A vaccine. The second approach was a prospective hospital-based active surveillance for hepatitis cases conducted in subjects (0–14years) during 2009–2011 at three sentinel hospitals in Panama.ResultsOverall, the annual incidence of hepatitis A and unspecified hepatitis in 2008, 2009 and 2010 were 13.1, 7.9 and 3.7 per 100,000 subjects, lower than the baseline incidence of 51.1 per 100,000 subjects. In comparison to the mean baseline period (2000–2006), there was an 82% mean reduction in the overall hepatitis-related outcomes (hepatitis A and unspecified hepatitis) after vaccine introduction (2008–2010) in all age groups.In the hospital-based surveillance (2009–2011), of the 42 probable viral hepatitis A cases, nine cases were confirmed as acute hepatitis A (8 in 2009, 1 in 2010). Of these confirmed cases, two belonged to the targeted vaccine group (1–4 years) but were not vaccinated.ConclusionsOur study suggests that the introduction of two-dose hepatitis A vaccines in Panama has contributed to the reduction in the incidence of overall hepatitis-related outcomes for all age groups, suggesting herd protection. Additional monitoring is required to document a sustained long-term effect.  相似文献   
49.
Background and aimsAssociations of alanine aminotransferase (ALT) and serum uric acid (SUA) with metabolic syndrome (MetS) remain controversial. We aimed to explore individual and combined effects of ALT and SUA on MetS in community residents.Methods and resultsA population-based cross-sectional survey involving randomly selected Chinese adults aged 35–74 years was conducted in 2009 in Qingdao, China, and 4642 participants were included in the current study. Based on a combination of SUA and ALT levels in the tertile, subjects were grouped into Group 1-9. The individual and combined relations of SUA and ALT to MetS were analyzed by logistic regression models. The prevalence of MetS was 28.50% in males and 22.30% in females. ALT and SUA were independently associated with MetS and ORs (95% CIs) were 1.55 (1.42–1.70) and 1.92 (1.72–2.14), respectively, after adjusting for potential confounders. With the elevation of ALT and SUA levels, the risk of developing MetS increased. Compared to Group 1, ORs (95% CIs) of combined ALT and SUA for MetS were 2.21 (1.70–2.88), 4.02 (3.10–5.21), 2.19 (1.62–2.97), 2.53 (1.91–3.34), 4.69 (3.60–6.12), 1.76 (1.17–2.64), 3.65 (2.63–5.06) and 7.15 (5.41–9.46) in Group 2–9, respectively.ConclusionsALT and SUA were both related to MetS independently. Combined elevation of ALT and SUA levels could increase the risk of MetS and its components than an elevation in SUA and ALT alone. Therefore, measures should be taken to lower SUA and ALT levels to reduce the risk of having MetS.  相似文献   
50.
INTRODUCTIONItisknownthatliverregeneratesquicklyinresponsetotisuedamage.Hepatocytegrowthfactor(HGF)hasbeenimplicatedintheregu...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号